Efficacy and safety of Saccharomyces boulardii CNCM I-745 for the treatment of pediatric acute diarrhea in China: a systematic review and meta-analysis
BackgroundPediatric acute gastroenteritis (PAGE) is a common cause of morbidity and mortality, especially in children under five years old. Therapeutic strategies including probiotics have been investigated, but trials from non-English speaking countries may not be easily accessible.AimTo determine...
Saved in:
| Main Authors: | Lynne V. McFarland, Tong Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Cellular and Infection Microbiology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fcimb.2025.1587792/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Saccharomyces boulardii (CNCM I-745) improves intestinal damage in sepsis by remodeling intestinal flora structure
by: Hui-Ying Liu, et al.
Published: (2025-07-01) -
Saccharomyces boulardii and Bifidobacterium co-treatment for antibiotic associated diarrhea in pediatrics: a multicenter efficacy and safety study
by: Qianfang Liu, et al.
Published: (2025-06-01) -
HE SACCHAROMYCES BOULARD II, AS A POTENTIAL PROBIOTIC FOR INNOVATIVE FOODS
by: S. A. Ryabtseva, et al.
Published: (2022-08-01) -
Effect of Saccharomyces boulardii supplementation to bismuth quadruple therapy on Helicobacter pylori eradication
by: Yi-Zhou Jiang, et al.
Published: (2025-04-01) -
Multi-step pathway engineering in probiotic Saccharomyces boulardii for abscisic acid production in the gut
by: Femke Van Gaever, et al.
Published: (2025-06-01)